No Abstract BioWorld International CorrespondentPARIS - Trophos received €7 million (US$9.77 million) in funding for two projects involving the company's lead candidate, TRO19622, one of several cholesterol-oxime-based compounds it is developing for the treatment of neurodegenerative diseases.
No Abstract BioWorld International CorrespondentPARIS - Domain Therapeutics SA, which was called Faust Pharmaceuticals SA until early December, has raised €2.1 million (US$2.8 million) to finance its drug discovery activities, which are focused on the identification of allosteric modulators of G Protein-Coupled Receptors (GPCRs).
No Abstract BioWorld International CorrespondentPARIS - Xentech, a contract research start-up specialized in evaluating the efficacy of anticancer therapies, raised seed capital of €600,000 (US$765,000) from Aurinvest Capital 2, indicating that would help it put together a €4 million development plan.
